Gaps in Research on Adverse Events to Transfusion in Pediatrics

Ronald Jackups1, William Savage2

  • 1St. Louis, MO.

Insights

Adverse effects of blood transfusions in children, including cytomegalovirus transmission and immune alterations, require further research to understand and prevent negative health outcomes. Minimizing transfusion-related morbidity in pediatric patients remains a key clinical challenge.

Area of Science:

  • Pediatric Hematology
  • Transfusion Medicine
  • Immunology

Background:

  • Adverse consequences of blood transfusions in children are not fully understood.
  • Mechanisms, avoidance, and minimization of transfusion-related morbidity in pediatric patients require further investigation.
  • All transfusion reactions can occur in children, necessitating focused research on pediatric-specific risks.

Purpose of the Study:

  • To review and highlight four adverse consequences of blood transfusion particularly relevant to pediatric populations.
  • To underscore the need for enhanced understanding of transfusion reactions in children.
  • To identify areas for future research in pediatric transfusion medicine.

Main Methods:

  • Literature review focusing on adverse transfusion events in pediatric populations.
  • Synthesis of current knowledge on specific transfusion-related complications.
  • Identification of key areas of concern for pediatric transfusion safety.

Main Results:

  • Cytomegalovirus transmission is a significant concern in pediatric transfusions.
  • Red blood cell alloimmunization poses risks for children receiving transfusions.
  • Transfusion-related immune-modulating effects (TRIM) are relevant in pediatric care.
  • Necrotizing enterocolitis is a potential adverse outcome linked to transfusions in neonates.

Conclusions:

  • Further research is crucial to elucidate the mechanisms and prevention strategies for transfusion complications in children.
  • Improved understanding is needed to minimize morbidity associated with blood transfusions in pediatric patients.
  • Specific adverse events like CMV transmission, alloimmunization, immune alteration, and necrotizing enterocolitis warrant targeted investigation in pediatric transfusion medicine.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.4K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312